摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-ethoxycarbonyl-3a,8-dimethyl-3-(4-nitrophenyl)-5-phenyl-3a,11-dihydro-4H-[1,2,4]triazolo[4,3-a][1,5]benzodiazepine | 216696-56-9

中文名称
——
中文别名
——
英文名称
1-ethoxycarbonyl-3a,8-dimethyl-3-(4-nitrophenyl)-5-phenyl-3a,11-dihydro-4H-[1,2,4]triazolo[4,3-a][1,5]benzodiazepine
英文别名
Ethyl 6,12-dimethyl-5-(4-nitrophenyl)-8-phenyl-2,4,5,9-tetraazatricyclo[8.4.0.0^{2,6}]tetradeca-1(14),3,8,10,12-pentaene-3-carboxylate;ethyl 3a,8-dimethyl-3-(4-nitrophenyl)-5-phenyl-4H-[1,2,4]triazolo[4,3-a][1,5]benzodiazepine-1-carboxylate
1-ethoxycarbonyl-3a,8-dimethyl-3-(4-nitrophenyl)-5-phenyl-3a,11-dihydro-4H-[1,2,4]triazolo[4,3-a][1,5]benzodiazepine化学式
CAS
216696-56-9
化学式
C27H25N5O4
mdl
——
分子量
483.527
InChiKey
HDCQHOFKVLJNOS-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    5.5
  • 重原子数:
    36
  • 可旋转键数:
    5
  • 环数:
    5.0
  • sp3杂化的碳原子比例:
    0.22
  • 拓扑面积:
    103
  • 氢给体数:
    0
  • 氢受体数:
    7

反应信息

  • 作为反应物:
    描述:
    N-(p-methyl)-phenyl-C-acetylformohydrazidoyl bromide1-ethoxycarbonyl-3a,8-dimethyl-3-(4-nitrophenyl)-5-phenyl-3a,11-dihydro-4H-[1,2,4]triazolo[4,3-a][1,5]benzodiazepine三乙胺 作用下, 以 为溶剂, 反应 40.0h, 以56%的产率得到1,7-diethoxycarbonyl-3a,10-dimethyl-3-(4-nitrophenyl)-5-(4-toyly)-3a,4a,8,13-tetrahydro-4H-bis[1,2,4-triazolo][4,3-a:3',4'-d][1,5]benzodiazepine
    参考文献:
    名称:
    Synthesis of New Tri- and Tetraheterocyclic Systems: 1,3-Dipolar Cycloaddition of Nitrilimines on 2,7-Dimethyl-4-Phenyl-3H-1,5-Benzodiazepine
    摘要:
    We report here a one-step synthesis of a new series of tri and tetraheterocyclic systems by the mixed condensation reactions of N-aryl-C-ethoxycarbonylnitrilimines and diarylnitrilimines with 2,7-dimethyl-4-phenyl-3H-1,5-benzodiazepine. This 1,3-dipolar cycloaddition is completely peri and regioselective. The structure of these products has been confirmed by H-1, C-13 NMR, mass spectroscopic and X-ray crystallographic analysis.
    DOI:
    10.1080/00397919809458689
  • 作为产物:
    描述:
    ethyl (2Z)-2-bromo-2-[(4-nitrophenyl)hydrazinylidene]acetate 、 1,5-benzodiazepine 在 三乙胺 作用下, 以 为溶剂, 反应 40.0h, 以92.2%的产率得到1-ethoxycarbonyl-3a,8-dimethyl-3-(4-nitrophenyl)-5-phenyl-3a,11-dihydro-4H-[1,2,4]triazolo[4,3-a][1,5]benzodiazepine
    参考文献:
    名称:
    Synthesis of New Tri- and Tetraheterocyclic Systems: 1,3-Dipolar Cycloaddition of Nitrilimines on 2,7-Dimethyl-4-Phenyl-3H-1,5-Benzodiazepine
    摘要:
    We report here a one-step synthesis of a new series of tri and tetraheterocyclic systems by the mixed condensation reactions of N-aryl-C-ethoxycarbonylnitrilimines and diarylnitrilimines with 2,7-dimethyl-4-phenyl-3H-1,5-benzodiazepine. This 1,3-dipolar cycloaddition is completely peri and regioselective. The structure of these products has been confirmed by H-1, C-13 NMR, mass spectroscopic and X-ray crystallographic analysis.
    DOI:
    10.1080/00397919809458689
点击查看最新优质反应信息

同类化合物

叔-丁基3-溴-8,9-二氢-5H-[1,2,4]三唑并[4,3-D][1,4]二氮杂卓-7(6H)-甲酸基酯 叔-丁基3-(羟甲基)-7,8-二氢-4H-[1,2,3]三唑并[1,5-A][1,4]二氮杂卓-5(6H)-甲酸基酯 乙基4-(4H-[1,2,4]三唑并[4,3-a][1,5]苯并二氮卓-5-基)哌嗪-1-羧酸酯 9H-[1,2,4]三唑并[4,3-a][1,4]二氮杂卓 9-氯-5,6-二氢-4-甲基-1-(2-噻吩基)-4H-[1,2,4]三唑并[4,3-a][1,5]苯并二氮杂卓 9-氯-1-(2-呋喃基)-5,6-二氢-4-甲基-4H-[1,2,4]三唑并[4,3-a][1,5]苯并二氮杂卓 8-氯-5-(4-甲基哌嗪-1-基)-6-苯基-[1,2,4]三唑并[4,3-a][1,5]苯并二氮杂卓 8-氯-1-甲基-5-(甲基硫烷基)-6-苯基-6H-[1,2,4]三唑并[4,3-a][1,5]苯并二氮卓 2-[(8-氯-6-苯基-6H-[1,2,4]三唑并[4,3-a][1,5]苯并二氮卓-5-基)硫烷基]-N,N-二甲基乙胺 2-[(8-氯-1-甲基-6-苯基-[1,2,4]三唑并[4,3-a][1,5]苯并二氮杂卓-5-基)硫基]-N,N-二甲基乙胺 1H-环丙并[d][1,2,4]三唑并[4,3-b]哒嗪 1H,5H-[1,2,4]三唑并[1,2-a][1,2]二氮杂卓-1,3,5(2H)-三酮,6,9-二氢-2,7-二甲基-9-(2-吡啶基)- (9ci)-1H-1,2,4-噻唑并[4,3-c][1,3]二氮杂卓 (9ci)-1H-1,2,4-噻唑并[4,3-a][1,4]二氮杂卓 3-(Trifluoromethyl)-6,7,8,9-tetrahydro-5H-[1,2,4]triazolo[4,3-D][1,4]diazepine [1,4-dioxy-3-(pyrrolidine-1-carbonyl)-quinoxalin-2-ylmethylene]-hydrazinecarboxylic acid methyl ester 2-methyl-hexahydro-6-thia-2,3a,7c-triaza-4,4e-cyclo-cyclopenta[1,3]cyclopropa[1,2-a]cyclopropa[cd]-as-indacene-1,3-dione 2-methyl-6,6-dioxo-octahydro-6λ6-thia-2,3a,7c-triaza-4,4e-cyclo-cyclopenta[1,3]cyclopropa[1,2-a]cyclopropa[cd]-as-indacene-1,3-dione (4as,4a1r,8aR,13aS)-11-methyldodecahydro-10H-heptaleno[1',10':3,4,5]pyrazolo[1,2-a][1,2,4]triazole-10,12(11H)-dione 8-chloro-1-methyl-6-phenyl-4H-<1,2,4>triazolo<4,3-a><1,5>benzodiazepine-5(6H)-thione N-methyl-4-oxa-8,9,13-triazaheptacyclo<9.5.1.02,6.02,10.06,14.07,12.013,17>heptadecane-8,9-dicarboximide 8-(octyloxy)-4,5-dihydrobenzo[b][1,2,4]triazolo[4,3-d][1,4]thiazepine 1,3,4-trimethyl-7-oxy-8-phenyl-4,6-dihydro-1H-pyrazolo[4,3-e][1,4]diazepin-5-one 7-methyl-6,7-dihydro-5H-benzo[f][1,2,4]triazolo[4,3-d][1,4]diazepine 1-methyl-6-phenyl-4,6-dihydro-benzo[b][1,2,4]triazolo[4,3-d][1,4]diazepin-5-one 4,4-dimethyl-10-phenyl-hexahydro-1,7;2,6-dicyclo-dicyclobuta[c,e]cyclopenta[d][1,2,4]triazolo[1,2-a]pyridazine-9,11-dione 2-[3-[(3,4-dichlorophenyl)methyl]-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]-N-(oxan-4-yl)-5-oxo-6,7-dihydrothieno[3,2-d]pyrimidin-4-amine 3-{5H,6H,8H-[1,2,4]triazolo[3,4-c][1,4]oxazin-3-yl}azetidine,bis(trifluoroaceticacid) 1-cyclohexyl-4-methyl-5,6-dihydro-4H-benzo[b][1,2,4]triazolo[4,3-d][1,4]diazepine 8-chloro-1-cyclohexyl-4-methyl-5,6-dihydro-4H-benzo[b][1,2,4]triazolo[4,3-d][1,4]diazepine 2-phenyl-4-(4-phenyl-3,6-dihydro-2H-pyridin-1-yl)-3H-benzo[b][1,4]diazepine (1α,7α,8β,11β)-syn-14-acetamido-4-methyl-2,4,6-triazatetracyclo<5.4.2.18,11.02,6>tetradecane-3,5-dione 9-chloro-1-(2,4-dichloro-phenyl)-4-methyl-5,6-dihydro-4H-benzo[b][1,2,4]triazolo[4,3-d][1,4]diazepine 12-(Hydroxyimino)-5-methyl-3,5,7-triazahexacyclo<7.5.02,13.03,7.08,11.010,14>tetradecane-4,6-dione 4-(benzyloxy)-1-methyl-8-chloro-6-phenyl-4H-s-triazolo[4,3-a][1,5]benzodiazepin-5-one 4-((R)-3-morpholin-4-yl-1-phenylsulfanylmethyl-propylamino)-N-(5,6,7,8-tetrahydro-4H-1,2,3a,6-tetraaza-azulen-3-yl)-3-trifluoromethanesulfonyl-benzenesulfonamide 7-[5-chloro-4-(1-methyl-1H-benzimidazol-2-yl)pyridin-2-yl]-3-cyclopropyl-6,7,8,9-tetrahydro-5H-[1,2,4]triazolo[4,3-d][1,4]diazepine tert-butyl 4-[(1R)-1-({[(6S)-6-(5-chloro-2-methoxybenzyl)-3,7-dioxo-6,7-dihydro-5H-[1,2,4]oxadiazolo[4,3-a][1,4]diazepin-8(9H)-yl]carbonyl}amino)propyl]-2-nitrobenzoate (32Z,51Z,71Z)-35,55,74-trimethyl-1(1,3)-benzena-3,5,7(1,3)-tricyclopentanacyclooctaphane-32,34,51,53,71,74-hexaene 7-methyl-4b,4c,4d,4e,5,8b-hexahydro-5a,7,8a-triaza-4a,5-cyclo-benzo[1,3]cyclopropa[1,2-a]cyclopropa[cd]-as-indacene-2,6,8-trione 2-[3-(2,4-Dibromo-phenyl)-5-phenyl-3H-[1,3,4]thiadiazol-(2E)-ylidene]-pentan-3-one 8-chloro-6-(2-chloro-phenyl)-1-methyl-4,6-dihydro-benzo[b][1,2,4]triazolo[4,3-d][1,4]diazepin-5-one 5-methyl-3,5,7-triazahexacyclo<7.5.0.02,13.03,7.08,11.010,14>tetradecane-4,6,12-trione 6,6a,6b,7,8,10,12a,12b-octahydro-2H,5H-bis[1,2,4]triazolo[4,3-a;4',3'-a']cyclobuta[1,2-c;3,4-e']dipyridine-3,11-dione 4-(3-aminopropyl)-1-methyl-8-chloro-6-phenyl-4H-s-triazolo-[4,3-a][1,5]benzodiazepin-5-one